25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The magnitude of the risk of incident type 2 diabetes (T2D) and metabolic syndrome (MetS) among patients with nonalcoholic fatty liver disease (NAFLD) is poorly known. We gauged the risk of developing T2D and MetS in patients with NAFLD diagnosed by either serum liver enzymes (aminotransferases or gamma-glutamyltransferase [GGT]) or ultrasonography.

          Related collections

          Author and article information

          Journal
          J. Gastroenterol. Hepatol.
          Journal of gastroenterology and hepatology
          1440-1746
          0815-9319
          May 2016
          : 31
          : 5
          Affiliations
          [1 ] Azienda USL, Internal Medicine, Pavullo Hospital, Pavullo, Italy.
          [2 ] University of Modena and Reggio Emilia, Metabolic Clinic, Infectious and Tropical Disease Unit, Policlinico Hospital, Modena, Italy.
          [3 ] Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
          [4 ] Azienda USL, Outpatient Liver Clinic and Internal Medicine, NOCSAE, Modena, Italy.
          [5 ] Department of Statistics, University of Bologna, Bologna, Italy.
          Article
          10.1111/jgh.13264
          26667191
          6791ab5a-d868-48f0-a755-6be4385d7557
          © 2015 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
          History

          ALT,AST,Diabetes,GGT,Liver enzymes,Metabolic Syndrome,NAFLD,Ultrasonography

          Comments

          Comment on this article